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s. X is a 15-year-old girl who presented for psychiatric evaluation with complaints of low mood, fatigue, and a "huge" appetite. She stated that her problems started about 6 months prior, coinciding with her family relocating to the United States from Central America. During her first month in the United States, Ms. X, who had no significant past psychiatric history, experienced a steady decline in her mental state. She was very low in mood with crying spells. She was withdrawn, anxious, tired with poor motivation, sleeping excessively, and had a poor appetite with associated weight loss. She became obsessed with her weight and took to running 6 miles daily, losing 13 lbs in 2 months. She was also binge eating, abusing laxatives, counting her calories, and avoiding foods that contained sugar and flour. She subsequently developed amenorrhea. Her abuse of laxatives stopped when she noticed bleeding in her stool. Ms. X, who used to be an excellent student, had no motivation for school work and developed severe anxiety in the mornings. She expressed feelings of worthlessness and hopelessness, with passive suicidal thoughts.
Her only stressor appeared to be her family's recent relocation to the United States, which led to adjusting to a new living environment and attending a new school. She had a very supportive family and a good relationship with her parents and two siblings. There was a family history of major depressive disorder (MDD) and generalized anxiety disorder (GAD). Both parents had a history of MDD managed with antidepressants. Several relatives had diagnoses of MDD and GAD and were also being treated with medication. There was also a family history of two autoimmune diseases: Hashimoto's thyroiditis and type 1 diabetes mellitus. The patient denied any history of substance abuse and had no history of physical, sexual, or emotional abuse.
Three months prior to her psychiatric evaluation, she had met with her primary care provider who started her on 10 mg/day of fluoxetine for her depressive and anxiety symptoms. She also had a follow-up with an endocrinologist, who suggested she might be hyperthyroid. A repeat test of her thyroid functions 1 week later showed her to be euthyroid. However, a few weeks later, Ms. X had another set of thyroid function tests done and this revealed low/normal thyroidstimulating hormone (TSH) with a low free T4 and low-normal T4. She also had positive anti-thyroid peroxidase antibodies. She was diagnosed with Hashimoto's thyroiditis and started on 50 mcg/day of levothyroxine that was later increased to 75 mcg/day. She became obsessed with her weight and took to running 6 miles daily, losing 13 lbs in 2 months.
She continued to complain of fatigue, and her repeat blood work continued to show low-normal free T4. Her fluoxetine dose was increased to 20 mg daily. Gradually, Ms. X noticed an improvement in her depressive symptoms and anxiety.
She also began to gain weight and described a voracious appetite. She was no longer selective of the type of food she ate and felt out of control with regard to food. She was so concerned with the amount of food she was consuming that she asked her parents to lock up food and snacks. Her parents were equally concerned and described this as the major issue during their initial psychiatric consultation. During this time, she also had regular conflicts with her siblings. She would eat her food, their food, and any snacks she could find. She became increasingly distressed because of her eating. She was no longer vomiting or purging, but she was so concerned that her mother called the doctor's office on several occasions inquiring about what could be done to curb her appetite.
DIAGNOSIS: Mood Disorder due to General Medical Condition (Hashimoto's Thyroiditis)
During her consultation in our outpatient clinic, she stated that she was doing much better and the major complaint that led to evaluation was her "out-of-control" appetite. The parents did not want to switch her from fluoxetine because her depression had improved. She had been seeing a therapist and had an appointment with a dietician. The timeline of symptom presentation made it difficult to ascertain whether she had her mood symptoms first or if they followed Hashimoto's thyroiditis. She also did not meet criteria for MDD during her initial evaluation. In view of this, Mood Disorder due to General Medical Condition (Hashimoto's thyroiditis) could not be ruled out. She was continued on the same medications, and subsequent follow-up revealed that she was doing quite well. Her thyroid function tests were normal and she expressed no depressive symptoms or hyperphagia.
DISCUSSION
Hashimoto's thyroiditis is an autoimmune condition that can cause a transient hyperthyroid state, followed by euthyroid and possibly hypothyroid states. It presents with elevated levels of anti-thyroid peroxidase antibodies in the serum. Its physical manifestations are quite varied and may include weight gain, sensitivity to heat and cold, paresthesia, constipation, migraines, muscle cramps, memory loss, hyperphagia, infertility, and hair loss. Some studies have suggested a relationship between autoimmune thyroid disease and psychiatric disorders, particularly depression and anxiety.
1,2 The prevalence of autoimmune thyroid disease in the general population ranges between 4% and 25%. 1, 3 This prevalence, in concert with the suggested association between autoimmune thyroid disease and psychiatric disorders, makes it important to properly diagnose and treat this condition. The chronology of symptom presentation made it difficult to draw a conclusive association between our patient's mental disorder and her thyroid dysfunction. However, it seemed likely that her psychiatric manifestations could have been a result of her autoimmune disorder. Making this theory more likely is the observed improvement in both her physical and mental symptoms when her thyroid condition was treated with levothyroxine. She was also on fluoxetine, a selective serotonin reuptake inhibitor, at the time. It may also be possible that she developed an affective disorder precipitated by adjusting to her new circumstances while simultaneously developing a thyroid disorder. Her strong family history of MDD and GAD makes this a possibility.
Another interesting observation in our patient was that she also presented with an eating disorder in addition to depressive symptoms and anxiety. Although the link with depression 4 It is important to highlight the association of thyroid autoimmunity with treatment outcome. It has been suggested that the presence of antithyroid antibodies predicts a poor response to standard antidepressant treatment. 6 On the contrary, other studies have suggested that the presence of subtle thyroid function abnormalities does not have an impact on treatment outcome. 4, 7 In our patient, some improvement in her symptoms was noted when she was on both fluoxetine and levothyroxine.
There have been suggestions that some psychiatric disorders and the autoimmune reaction seem to be rooted in the same aberrancy in the immune-endocrine system. 1 Carta and colleagues 1 are of the opinion that if these findings are confirmed in future, it may be advisable to systematically screen for mood disorders in patients with anti-thyroid peroxidase antibodies, and also evaluate for thyroid diseases and thyroid autoimmunity in patients with mood disorders. For now, it remains critical that clinicians have a high index of suspicion for mood disorders that may be secondary to a general medical condition.
